“Meet Vivek Ramaswamy. He’s the 34-year-old CEO of Roivant Sciences, a biopharma working on a therapeutic to treat the COVID-19 cytokine storm (among many other drugs) and member of Ohio’s coronavirus task force… the “holy grail” in COVID-19 breakthroughs would be a universal, widely available, safe, and effective vaccine, he says—but “our national strategy can't be predicated on it… “
“Meet Vivek Ramaswamy. He’s the 34-year-old CEO of Roivant Sciences, a biopharma working on a therapeutic to treat the COVID-19 cytokine storm (among many other drugs) and member of Ohio’s coronavirus task force… the “holy grail” in COVID-19 breakthroughs would be a universal, widely available, safe, and effective vaccine, he says—but “our national strategy can't be predicated on it… “
Vivek Ramaswamy is not who he is claiming to be.